11 analysts have shared their evaluations of Cognex CGNX during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 5 | 0 | 1 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 2 | 0 | 2 | 0 | 1 |
2M Ago | 0 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 2 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $44.82, a high estimate of $56.00, and a low estimate of $35.00. Observing a downward trend, the current average is 4.23% lower than the prior average price target of $46.80.
Deciphering Analyst Ratings: An In-Depth Analysis
A clear picture of Cognex's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Tommy Moll | Stephens & Co. | Maintains | Overweight | $55.00 | $55.00 |
Joe Ritchie | Goldman Sachs | Lowers | Sell | $35.00 | $39.00 |
Damian Karas | UBS | Lowers | Buy | $56.00 | $58.00 |
Richard Eastman | Baird | Lowers | Neutral | $38.00 | $42.00 |
Jamie Cook | Truist Securities | Lowers | Hold | $37.00 | $43.00 |
James Ricchiuti | Needham | Lowers | Buy | $41.00 | $47.00 |
Jamie Cook | Truist Securities | Raises | Hold | $43.00 | $42.00 |
Piyush Avasthy | Citigroup | Lowers | Neutral | $42.00 | $44.00 |
Tommy Moll | Stephens & Co. | Maintains | Overweight | $55.00 | $55.00 |
Troy Jensen | Cantor Fitzgerald | Announces | Overweight | $49.00 | - |
Jamie Cook | Truist Securities | Lowers | Hold | $42.00 | $43.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cognex. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cognex compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Cognex's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cognex's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Cognex analyst ratings.
Get to Know Cognex Better
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
Breaking Down Cognex's Financial Performance
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Cognex's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 16.79% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Cognex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 12.34% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cognex's ROE stands out, surpassing industry averages. With an impressive ROE of 1.84%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cognex's ROA excels beyond industry benchmarks, reaching 1.4%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
Understanding the Relevance of Analyst Ratings
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.